Stocks Health care ANEB

OTC · Health care

Anebulo Pharmaceuticals, Inc. (ANEB)

It posted a net loss of $8M. At December 31, 2025 it held $9M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on February 12, 2026.

Watch ANEB in 60 seconds

What Anebulo Pharmaceuticals, Inc. does

Anebulo Pharmaceuticals, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker ANEB.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Anebulo Pharmaceuticals, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. March 2, 2026
   Deregistration 15-12G
2. February 17, 2026
   Form 25 filing 25
3. February 13, 2026
   Passive stake changed SCHEDULE 13G/A
4. February 12, 2026
   Quarterly report 10-Q · period to December 31, 2025Diluted EPS -$0.05 versus -$0.09.
5. February 12, 2026
   Quarterly results 8-K
6. February 6, 2026
   Stock exchange listing notice 8-K
7. January 29, 2026
   Form SC 13E3/A filing SC 13E3/A
8. January 29, 2026
   Other event 8-K
9. January 27, 2026
   Form SC 13E3/A filing SC 13E3/A
10. January 27, 2026
    Other event 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on April 7, 2025. Insider transactions on SEC

Who owns ANEB

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about ANEB

What does Anebulo Pharmaceuticals, Inc. do?

Anebulo Pharmaceuticals, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker ANEB.

Is Anebulo Pharmaceuticals, Inc. profitable?

No. Over the twelve months to December 31, 2025 it reported a net loss of $8M.

When did Anebulo Pharmaceuticals, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on February 12, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the deregistration from March 2, 2026.

Similar companies

Compare ANEB with

Compare ANEB with any company

Follow ANEB

Get an email when Anebulo Pharmaceuticals, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow ANEB: get an email when it files

Where the numbers come from

Financial figures are the values Anebulo Pharmaceuticals, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.